BARD1 and breast cancer: Thompson et al. suggested that BARD1 mutations were associated with moderate BC risk (OR = 3.0, p = 0.62) by comparing 2000 BRCA1/2-negative BC patients with geographically matched controls, though not reaching statistical significance [45].